The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.

The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...

Researchers at the University of Rochester Medical Center (URMC) are delving into the effects of small, repetitive hits to ...

The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...